Participants with @ to @ RFs in control during follow-up had a @-fold higher risk of death ( hazard ratio : @ ; @ % confidence interval : @ to @ ; p = @ ) and a @-fold higher risk of the composite endpoint ( hazard ratio : @ ; @ % confidence interval : @ to @ ; p = @ ) , compared with those with @ RFs in control .